HER 2 and EGFR: signaling mechanisms and targets for anti-cancer therapies

被引：0
|
作者：
Yosef, Yarden [1 ]
机构：
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
来源：
TUMOR BIOLOGY | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [1] Telomere and telomerase as targets for anti-cancer and regeneration therapies
    Hsu, YH
    Lin, JJ
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (05) : 513 - 518
  • [2] Telomere and telomerase as targets for anti-cancer and regeneration therapies
    Yi-hsin Hsu
    Jing-jer Lin
    Acta Pharmacologica Sinica, 2005, 26 : 513 - 518
  • [3] Telomere and telomerase as targets for anti-cancer and regeneration therapies
    Yi-hsin HSU
    Acta Pharmacologica Sinica, 2005, (05) : 513 - 518
  • [4] The use of Cox-2 and PPARγ signaling in anti-cancer therapies
    Knopfova, Lucia
    Smarda, Jan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (02) : 257 - 264
  • [5] Defective cell cycle checkpoints as targets for anti-cancer therapies
    Gabrielli, Brian
    Brooks, Kelly
    Pavey, Sandra
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [6] Molecular targets and mechanisms of anti-cancer effects of withanolides
    Zhang, Zhiruo
    Yang, Yueying
    Xu, Yang
    Liu, Yang
    Li, Hua
    Chen, Lixia
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 384
  • [7] Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+breast cancer
    Gagliato, Debora de Melo
    Fontes Jardim, Denis Leonardo
    Pereira Marchesi, Mario Sergio
    Hortobagyi, Gabriel N.
    ONCOTARGET, 2016, 7 (39) : 64431 - 64446
  • [8] Cancer stem cell antigens as targets for new combined anti-cancer therapies
    Quaglino, Elena
    Cavallo, Federica
    Conti, Laura
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2020, 129
  • [9] Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer Drugs
    Kim, Hyuna
    Kim, Youngmi
    Goh, Hyeonjung
    Jeoung, Dooil
    MOLECULES AND CELLS, 2016, 39 (03) : 229 - 241
  • [10] Mechanisms of resistance to anti-EGFR/HER2 therapy in breast cancer
    Borrero-Garcia, Luis Daniel
    Vidal, Brian
    Dharmawardhane, Suranganie
    CANCER RESEARCH, 2018, 78 (13)
12345